PLIANT THERAPEUTICS, INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
PLIANT THERAPEUTICS, INC. (PLRX) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$56.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-11
- PLIANT THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$56.00K.
- PLIANT THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$326.00K.
- PLIANT THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was -$49.00K.
- PLIANT THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $35.00K, a 97.61% decline year-over-year.
- PLIANT THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was -$336.00K.
- PLIANT THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$24.00K, a 101.04% decline from fiscal 2023.
- PLIANT THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $2.30M.
- PLIANT THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$1.76M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$56.00K 10-Q · filed 2026-08-11 | -$382.00K 10-Q · filed 2026-08-11 | -$431.00K derived: sum of 3 quarters · filed 2026-08-11 | -$396.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$326.00K 10-Q · filed 2026-05-11 | -$375.00K derived: sum of 2 quarters · filed 2026-05-11 | -$340.00K derived: sum of 3 quarters · filed 2026-05-11 | -$500.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$14.00K derived: sum of 2 quarters · filed 2026-03-11 | -$174.00K derived: sum of 3 quarters · filed 2026-08-11 | -$336.00K 10-K · filed 2026-03-11 |
| 2025-09-30 | $35.00K 10-Q · filed 2025-11-06 | -$125.00K derived: sum of 2 quarters · filed 2026-08-11 | -$287.00K 10-Q · filed 2025-11-06 | -$814.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$160.00K 10-Q · filed 2026-08-11 | -$322.00K 10-Q · filed 2026-08-11 | -$849.00K derived: sum of 3 quarters · filed 2026-08-11 | $616.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$162.00K 10-Q · filed 2026-05-11 | -$689.00K derived: sum of 2 quarters · filed 2026-05-11 | $776.00K derived: sum of 3 quarters · filed 2026-05-11 | $648.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$527.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $938.00K derived: sum of 2 quarters · filed 2026-03-11 | $810.00K derived: sum of 3 quarters · filed 2026-03-11 | -$24.00K 10-K · filed 2026-03-11 |
| 2024-09-30 | $1.47M 10-Q · filed 2025-11-06 | $1.34M derived: sum of 2 quarters · filed 2025-11-06 | $503.00K 10-Q · filed 2025-11-06 | $2.75M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$128.00K 10-Q · filed 2025-08-07 | -$962.00K 10-Q · filed 2025-08-07 | $1.29M derived: sum of 3 quarters · filed 2025-08-07 | $1.62M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$834.00K 10-Q · filed 2025-05-08 | $1.42M derived: sum of 2 quarters · filed 2025-05-08 | $1.75M derived: sum of 3 quarters · filed 2025-05-08 | $842.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $2.59M derived: sum of 2 quarters · filed 2025-03-03 | $1.68M derived: sum of 3 quarters · filed 2025-03-03 | $2.30M 10-K · filed 2025-03-03 |
| 2023-09-30 | $334.00K 10-Q · filed 2024-11-07 | -$576.00K derived: sum of 2 quarters · filed 2024-11-07 | $51.00K 10-Q · filed 2024-11-07 | $547.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$910.00K 10-Q · filed 2024-08-07 | -$283.00K 10-Q · filed 2024-08-07 | $213.00K derived: sum of 3 quarters · filed 2025-03-03 | -$982.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $627.00K 10-Q · filed 2024-05-06 | $1.12M derived: sum of 2 quarters · filed 2025-03-03 | -$72.00K derived: sum of 3 quarters · filed 2025-03-03 | -$381.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $496.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$699.00K derived: sum of 2 quarters · filed 2025-03-03 | -$1.01M derived: sum of 3 quarters · filed 2025-03-03 | -$1.76M 10-K · filed 2025-03-03 |
| 2022-09-30 | -$1.20M 10-Q · filed 2023-11-09 | -$1.50M derived: sum of 2 quarters · filed 2023-11-09 | -$2.25M 10-Q · filed 2023-11-09 | -$2.41M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$309.00K 10-Q · filed 2023-08-09 | -$1.06M 10-Q · filed 2023-08-09 | -$1.22M derived: sum of 3 quarters · filed 2024-02-27 | -$1.23M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$749.00K 10-Q · filed 2023-05-09 | -$910.00K derived: sum of 2 quarters · filed 2024-02-27 | -$920.00K derived: sum of 3 quarters · filed 2024-02-27 | -$932.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$171.00K derived: sum of 2 quarters · filed 2024-02-27 | -$183.00K derived: sum of 3 quarters · filed 2024-02-27 | -$169.00K 10-K · filed 2024-02-27 |
| 2021-09-30 | -$10.00K 10-Q · filed 2022-11-08 | -$22.00K derived: sum of 2 quarters · filed 2022-11-08 | -$8.00K 10-Q · filed 2022-11-08 | -$22.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$12.00K 10-Q · filed 2022-08-08 | $2.00K 10-Q · filed 2022-08-08 | -$12.00K derived: sum of 3 quarters · filed 2022-08-08 | $0.00 derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $14.00K 10-Q · filed 2022-05-09 | $0.00 derived: sum of 2 quarters · filed 2022-05-09 | $12.00K derived: sum of 3 quarters · filed 2022-05-09 | -$77.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$2.00K derived: sum of 2 quarters · filed 2022-03-01 | -$91.00K derived: sum of 3 quarters · filed 2022-03-01 | -$31.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $12.00K 10-Q · filed 2021-11-09 | -$77.00K derived: sum of 2 quarters · filed 2021-11-09 | -$17.00K 10-Q · filed 2021-11-09 | -$19.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$89.00K 10-Q · filed 2021-08-09 | -$29.00K 10-Q · filed 2021-08-09 | -$31.00K derived: sum of 3 quarters · filed 2022-03-01 | -$41.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $60.00K 10-Q · filed 2021-05-10 | $58.00K derived: sum of 2 quarters · filed 2022-03-01 | $48.00K derived: sum of 3 quarters · filed 2022-03-01 | $56.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$12.00K derived: sum of 2 quarters · filed 2022-03-01 | -$4.00K derived: sum of 3 quarters · filed 2022-03-01 | -$1.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | -$10.00K 10-Q · filed 2020-11-10 | -$2.00K derived: sum of 2 quarters · filed 2020-11-10 | $1.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $8.00K 10-Q · filed 2020-08-11 | $11.00K 10-Q · filed 2020-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |